Aurora Spine Corp (ASG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Aurora Spine Corp (ASG) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-12.85K ≈ $-9.29K USD) by net assets (CA$3.62 Million ≈ $2.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Aurora Spine Corp fund operations to measure how many days the company can operate on defensive assets alone.
Aurora Spine Corp - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Aurora Spine Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Aurora Spine Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aurora Spine Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mico BioMed Co. Ltd.
KQ:214610
|
-0.315x |
|
Moleculin Biotech Inc
NASDAQ:MBRX
|
-0.358x |
|
Prochem S.A.
WAR:PRM
|
0.020x |
|
SSR Inc
KQ:275630
|
0.043x |
|
Wooree Lighting Co.Ltd
KQ:037400
|
-0.060x |
|
OSR Holdings Inc
NASDAQ:OSRH
|
-0.008x |
|
Bd Multimedia
PA:ALBDM
|
0.061x |
|
High Coast Distillery AB
ST:HIGHCO-B
|
0.005x |
Annual Cash Flow Conversion Efficiency for Aurora Spine Corp (2012–2025)
The table below shows the annual cash flow conversion efficiency of Aurora Spine Corp from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see ASG company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$3.81 Million ≈ $2.76 Million |
CA$917.37K ≈ $663.61K |
0.241x | +0.01% |
| 2024-12-31 | CA$4.40 Million ≈ $3.18 Million |
CA$1.06 Million ≈ $765.25K |
0.241x | +236.29% |
| 2023-12-31 | CA$5.30 Million ≈ $3.83 Million |
CA$-935.06K ≈ $-676.41K |
-0.177x | +51.08% |
| 2022-12-31 | CA$4.32 Million ≈ $3.12 Million |
CA$-1.56 Million ≈ $-1.13 Million |
-0.361x | +5.62% |
| 2021-12-31 | CA$5.57 Million ≈ $4.03 Million |
CA$-2.13 Million ≈ $-1.54 Million |
-0.382x | -505.26% |
| 2020-12-31 | CA$3.28 Million ≈ $2.37 Million |
CA$309.57K ≈ $223.94K |
0.094x | +22780.75% |
| 2019-12-31 | CA$1.77 Million ≈ $1.28 Million |
CA$729.00 ≈ $527.35 |
0.000x | -99.72% |
| 2018-12-31 | CA$2.96 Million ≈ $2.14 Million |
CA$435.79K ≈ $315.24K |
0.147x | +121.24% |
| 2017-12-31 | CA$1.65 Million ≈ $1.19 Million |
CA$-1.15 Million ≈ $-828.63K |
-0.694x | -41.82% |
| 2016-12-31 | CA$3.47 Million ≈ $2.51 Million |
CA$-1.70 Million ≈ $-1.23 Million |
-0.489x | +34.12% |
| 2015-12-31 | CA$4.69 Million ≈ $3.39 Million |
CA$-3.48 Million ≈ $-2.52 Million |
-0.742x | +63.57% |
| 2014-12-31 | CA$3.50 Million ≈ $2.53 Million |
CA$-7.13 Million ≈ $-5.16 Million |
-2.038x | +6.72% |
| 2013-12-31 | CA$1.44 Million ≈ $1.04 Million |
CA$-3.15 Million ≈ $-2.28 Million |
-2.184x | +73.39% |
| 2012-12-31 | CA$158.51K ≈ $114.66K |
CA$-1.30 Million ≈ $-941.41K |
-8.210x | -- |
About Aurora Spine Corp
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar inter… Read more